INmune Bio
Price & Volume
Stats
See more52W Range | $1.38-$10.50 |
Market Cap | $45.1M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $50,000 |
Revenue Growth (YoY) | 257.1% |
Gross Profit (12 Mos) | $50,000 |
Diluted EPS | -$2.08 |
News
See moreYahoo Finance • 20 days ago
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
Yahoo Finance • 24 days ago
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
Yahoo Finance • last month
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
Yahoo Finance • 2 months ago
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
About
CEO | Mr. David J. Moss M.B.A. |
Address | 225 NE Mizner Blvd., Boca Raton, FL, United States, 33432 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
